Company Valuation: Profarma Distribuidora de Produtos Farmacêuticos S.A.

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 747.9 723.4 450 747.9 795.7 1,119
Change - -3.28% -37.8% 66.21% 6.39% 40.68%
Enterprise Value (EV) 1 1,277 1,482 1,291 1,698 1,813 2,286
Change - 16.05% -12.88% 31.53% 6.77% 26.1%
P/E 14.3x 9.25x 5.56x 10.6x 6.95x 9.42x
PBR 0.71x 0.67x 0.38x 0.6x 0.61x 0.83x
PEG - 0.2x 1.62x -0.8x 0.1x 2.46x
Capitalization / Revenue 0.14x 0.11x 0.06x 0.09x 0.08x 0.1x
EV / Revenue 0.23x 0.23x 0.17x 0.2x 0.18x 0.2x
EV / EBITDA 8.52x 9.11x 4.54x 5.74x 5.3x 5.65x
EV / EBIT 9.95x 10.9x 5.09x 6.5x 6.05x 6.53x
EV / FCF -50.4x -136x -22.6x -101x 11.3x 34.7x
FCF Yield -1.98% -0.73% -4.42% -0.99% 8.82% 2.88%
Dividend per Share 2 - 0.2706 0.1733 0.3858 0.575 -
Rate of return - 4.59% 4.72% 6.32% 8.86% -
EPS 2 0.4268 0.6377 0.6596 0.574 0.934 0.9697
Distribution rate - 42.4% 26.3% 67.2% 61.6% -
Net sales 1 5,481 6,413 7,816 8,662 10,154 11,451
EBITDA 1 149.9 162.7 284.2 295.6 342.1 404.5
EBIT 1 128.3 136.3 253.8 261.1 299.7 350.1
Net income 1 52.33 78.19 80.87 70.4 114.6 118.9
Net Debt 1 528.9 758.4 840.9 950 1,017 1,167
Reference price 2 6.100 5.900 3.670 6.100 6.490 9.130
Nbr of stocks (in thousands) 122,611 122,611 122,611 122,611 122,611 122,611
Announcement Date 3/16/21 3/16/22 3/15/23 3/7/24 3/18/25 3/17/26
1BRL in Million2BRL
Estimates

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 168M
22.25x0.24x13.97x0.42% 101B
22.99x0.21x12.92x0.89% 54.69B
46.71x3.29x30.61x1.33% 24.3B
11.67x0.2x4.97x2.61% 8.24B
13.41x1.02x8.22x2.52% 7.73B
5.85x0.1x2.69x5.06% 6.64B
9.3x1.74x5.55x3.54% 6.33B
24.43x1.12x14.06x3.14% 4.98B
10.93x0.12x4.49x4.13% 3.74B
Average 18.61x 0.89x 10.83x 2.63% 21.81B
Weighted average by Cap. 23.43x 0.66x 14.27x 1.15%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. PFRM3 Stock
  4. Valuation Profarma Distribuidora de Produtos Farmacêuticos S.A.